Anatomical Therapeutic Chemical • L01FX03 • catumaxomab

A Alimentary tract and metabolism

B Blood and blood forming organs

C Cardiovascular system

D Dermatologicals

G Genito urinary system and sex hormones

H Systemic hormonal preparations, excluding sex hormones and insulins

J Antiinfectives for systemic use

L Antineoplastic and immunomodulating agents

L01 Antineoplastic agents

L01A Alkylating agents

L01B Antimetabolites

L01C Plant alkaloids and other natural products

L01D Cytotoxic antibiotics and related substances

L01E Protein kinase inhibitors

L01F Monoclonal antibodies and antibody drug conjugates

L01FA Cd20 (clusters of differentiation 20) inhibitors

L01FB Cd22 (clusters of differentiation 22) inhibitors

L01FC Cd38 (clusters of differentiation 38) inhibitors

L01FD Her2 (human epidermal growth factor receptor 2) inhibitors

L01FE Egfr (epidermal growth factor receptor) inhibitors

L01FF Pd-1/pdl-1 (programmed cell death protein 1/death ligand 1) inhibitors

L01FG Vegf/vegfr (vascular endothelial growth factor) inhibitors

L01FX Other monoclonal antibodies and antibody drug conjugates

L01FX02 gemtuzumab ozogamicin

L01FX03 catumaxomab

L01FX04 ipilimumab

L01FX09 mogamulizumab

L01FX12 tafasitamab

L01FX13 enfortumab vedotin

L01FX14 polatuzumab vedotin

L01FX17 sacituzumab govitecan

L01FX18 amivantamab

L01FX20 tremelimumab

L01FX22 loncastuximab tesirin

L01FX24 teclistamab

L01FX25 mosunetuzumab

L01FX26 mirvetuximab soravtansin

L01FX27 epcoritamab

L01FX28 glofitamab

L01FX29 talquetamab

L01FX31 zolbetuximab

L01FY Combinations of monoclonal antibodies and antibody drug conjugates

L01X Other antineoplastic agents

L02 Endocrine therapy

L03 Immunostimulants

L04 Immunosuppressants

M Musculo-skeletal system

N Nervous system

P Antiparasitic products, insecticides and repellents

R Respiratory system

S Sensory organs

V Various